	Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer. JAMA Netw Open Farolfi A, Casadei C, Scarpi E, Paoletti E, Gianni C, Palleschi M, Gentili N, Mariotti M, Testoni S, Di Menna G, Rusconi F, Andalò A, Serra O, Merloni F, Sirico M, Maltoni R, Cecconetto L, Sarti S, Musolino A. PMID: 42446878 [PubMed - indexed for MEDLINE]
	Educational, Racial, and Geographic Inequalities in Breast Cancer Screening and Diagnosis among Brazilian Women. J Racial Ethn Health Disparities Santana FG, de Branco FMS, Cunha KS, Rezende LFM, Azeredo CM. PMID: 42446866 [PubMed - as supplied by publisher]
	Correction: Fatigue, physical and daily activity, and self-perceived work ability in cancer survivors: a long-term follow-up study with a matched non-cancer reference group. J Cancer Surviv Tödt K, Engström M, Ekström M, Heiden M, de Boer AGEM, Efverman A. PMID: 42446864 [PubMed - as supplied by publisher]
	Real-world clinical outcomes of intermediate-risk PAM50 (i-ROR) in HR+/HER2- early breast cancer and eligibility for adjuvant CDK4/6 inhibitors. Breast Cancer Res Treat Terán S, Illia M, Quevedo MC, Moreno ML, Bianchi MA, Lema L, González C, Tolosa P, Madariaga A, Manso L, Ruano Y, Parrilla L, Cobos MÁ, Ciruelos E, Sánchez-Bayona R. PMID: 42446834 [PubMed - indexed for MEDLINE]
	The Impact of Prostate Cancer Treatment on Work Participation: A Systematic Review. J Occup Rehabil Tomic D, Schellack SK, Abdel-Malek L, Jander C, Hettige ST, MacFarlane E, Millar J, Walker-Bone K. PMID: 42446789 [PubMed - as supplied by publisher]
	Return to Work and Employment Outcomes in Survivors of Differentiated Thyroid Cancer: A Systematic Review. J Occup Rehabil Sirbu AM, Oancea C, Sirbu OM, Cernamoriti A, Paun DL. PMID: 42446788 [PubMed - as supplied by publisher]
	Prophylactic vs. reactive percutaneous endoscopic gastrostomy (PEG) tubes in head and neck cancer: a meta-analysis of survival and supportive care outcomes. Support Care Cancer Alqutub A, Almuqati M, Khan MF, Mania K, Althubaiti RS, Althobaiti HK, Najem NH, Altowairqi AF, Almasoudi SM, Shosho RY, Alwzyani AM, Merdad M. PMID: 42446784 [PubMed - in process]
	Automated model-based lesion tracking in CT: colorectal liver metastases as a use case for development and performance analysis. Eur Radiol Exp Karunanayake N, Yang H, Geng P, Li Q, Yin P, Do RK, Schwartz LH, Lu L, Zhao B. PMID: 42446777 [PubMed - indexed for MEDLINE]
	lncRNA MEG3 and Beclin-1 as diagnostic biomarkers in serous ovarian carcinoma: molecular and immunohistochemical insights. J Mol Histol El Desoky AMZ, Abdelgeleel HM, Moustafa M, Abdalrahman MAM, Eldaly MM. PMID: 42446766 [PubMed - indexed for MEDLINE]
	Rewiring cancer cell fate toward vasculogenic mimicry: from classical to unconventional processes. Cancer Metastasis Rev Méndez-Pérez EA, García-Quiroz J, Avila E, García-Becerra R, Díaz L. PMID: 42446762 [PubMed - in process]
	How do mothers with advanced cancer experience anxiety about present and future of their children aged 6-12Â years: a phenomenological interview study. Support Care Cancer Aflaki F, Namani E. PMID: 42446742 [PubMed - indexed for MEDLINE]
	Comparative safety profiles of enzalutamide, olaparib, and lutetium Lu-177 vipivotide tetraxetan in patients with prostate cancer: a real-world disproportionality analysis of the FAERS database. World J Urol Li R, Li T, Yu J, Niu Y. PMID: 42446704 [PubMed - indexed for MEDLINE]
	Direct targeting of GLUT1 in cancer: A decade of inhibitor discovery and medicinal chemistry insights. Med Chem Res Meng Z, Tian E, Hu W, Ren C, Li J. PMID: 42446694 [PubMed - in process]
	Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches. Med Chem Res Shagufta, Ahmad I, Bazbouz LZ, Eissa AW, Abdellatif S. PMID: 42446692 [PubMed - indexed for MEDLINE]
	Chalcones as multitarget modulators in non-small cell lung cancer: mechanistic insights and therapeutic perspectives. Arch Toxicol Cruz EMS, Concato-Lopes VM, Detoni MB, Gonçalves-Lens MD, de Souza MC, Inoue FSR, Nunes AP, da Silva Siqueira E, Rodrigues ACJ, Dos Santos-Destro YM, Santos NC, de Sousa Silva JM, da Silva ÉI, Providello MV, Lazarin-Bidóia D, Seiva FRF, Pavanelli WR. PMID: 42446675 [PubMed - as supplied by publisher]
	Revisiting two-stage models of chemically-induced cirrhosis-associated hepatocarcinogenesis in rodents: methodological and histopathological approaches. J Mol Histol da Fonseca ARB, de Magalhães Junior PFC, Barbisan LF. PMID: 42446627 [PubMed - indexed for MEDLINE]
	Emerging target antigen landscape for CAR T-cell therapy in solid tumors: current advances and future directions. Immunol Res Chakraborty D, Kundu S, Rawal SK, Mani S. PMID: 42446608 [PubMed - indexed for MEDLINE]
	[Stereotactic radiotherapy for primary renal cell carcinoma: new findings from the FASTRACK trials]. Strahlenther Onkol Trommer M, Dunst J. PMID: 42446589 [PubMed - as supplied by publisher]
	Extracellular Vesicles as Emerging Cervical Cancer Diagnostic and Molecular Signatures of Tumor and Immune Dynamics. ACS Biomater Sci Eng Wahid A, Maharaj R, Meiring M, Anand K. PMID: 42446503 [PubMed - as supplied by publisher]
	Tumor necrosis factor alpha-induced protein3 rs;10499194 polymorphism enhances presepsin and sCD64 accuracy in differentiating infection from rheumatoid arthritis flare. Egypt J Immunol Mohammed FH, Al-Jameel DSA, Hamzah AA. PMID: 42446483 [PubMed - in process]

Articles 1 - 20 / 1955051

Page 1 of 97753



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy